0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and United States Mental Disorders Drugs Market Insights, Forecast to 2027
Published Date: August 2021
|
Report Code: QYRE-Auto-12T6869
Home | Market Reports | Health | Mental Health
Global and United States Mental Disorders Drugs Market Insights Forecast to 2027

Global and United States Mental Disorders Drugs Market Insights, Forecast to 2027

Code: QYRE-Auto-12T6869
Report
August 2021
130 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
Mental Disorders Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Mental Disorders Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For United States market, this report focuses on the Mental Disorders Drugs market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in United States.

Segment by Type

Drugs for Schizophrenia
Antidepressants
Antipsychotics
Anxiolytics
Drugs for the Treatment of Substance and Alcohol Addiction
Drugs for Childhood and Adolescent Mental Illness
Drugs to Treat Cognitive Disorders
Sleep Disorders
Others

Segment by Application

Children
Adolescents
Adults

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

BY COMPANY

Johnson & Johnson
Pfizer
Eli Lilly
GlaxoSmithKline
AstraZeneca
Bristol-Myers Squibb
Abbott Laboratories
1 Study Coverage
1.1 Mental Disorders Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Mental Disorders Drugs Market Size Growth Rate by Type
1.2.2 Drugs for Schizophrenia
1.2.3 Antidepressants
1.2.4 Antipsychotics
1.2.5 Anxiolytics
1.2.6 Drugs for the Treatment of Substance and Alcohol Addiction
1.2.7 Drugs for Childhood and Adolescent Mental Illness
1.2.8 Drugs to Treat Cognitive Disorders
1.2.9 Sleep Disorders
1.2.10 Others
1.3 Market by Application
1.3.1 Global Mental Disorders Drugs Market Size Growth Rate by Application
1.3.2 Children
1.3.3 Adolescents
1.3.4 Adults
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Mental Disorders Drugs Market Size, Estimates and Forecasts
2.1.1 Global Mental Disorders Drugs Revenue 2016-2027
2.1.2 Global Mental Disorders Drugs Sales 2016-2027
2.2 Global Mental Disorders Drugs, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Mental Disorders Drugs Historical Market Size by Region (2016-2021)
2.3.1 Global Mental Disorders Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Mental Disorders Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Mental Disorders Drugs Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Mental Disorders Drugs Sales Forecast by Region (2022-2027)
2.4.2 Global Mental Disorders Drugs Revenue Forecast by Region (2022-2027)
3 Global Mental Disorders Drugs Competitor Landscape by Players
3.1 Global Top Mental Disorders Drugs Manufacturers by Sales
3.1.1 Global Mental Disorders Drugs Sales by Manufacturer (2016-2021)
3.1.2 Global Mental Disorders Drugs Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Mental Disorders Drugs Manufacturers by Revenue
3.2.1 Key Mental Disorders Drugs Manufacturers Covered: Ranking by Revenue
3.2.2 Global Mental Disorders Drugs Revenue by Manufacturers (2016-2021)
3.2.3 Global Mental Disorders Drugs Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Mental Disorders Drugs Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Mental Disorders Drugs Revenue in 2020
3.2.6 Global Mental Disorders Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Mental Disorders Drugs Price by Manufacturers
3.4 Global Mental Disorders Drugs Manufacturing Base Distribution, Product Types
3.4.1 Mental Disorders Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Mental Disorders Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Mental Disorders Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Mental Disorders Drugs Market Size by Type (2016-2021)
4.1.1 Global Mental Disorders Drugs Sales by Type (2016-2021)
4.1.2 Global Mental Disorders Drugs Revenue by Type (2016-2021)
4.1.3 Mental Disorders Drugs Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Mental Disorders Drugs Market Size Forecast by Type (2022-2027)
4.2.1 Global Mental Disorders Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Mental Disorders Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Mental Disorders Drugs Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Mental Disorders Drugs Market Size by Application (2016-2021)
5.1.1 Global Mental Disorders Drugs Sales by Application (2016-2021)
5.1.2 Global Mental Disorders Drugs Revenue by Application (2016-2021)
5.1.3 Mental Disorders Drugs Price by Application (2016-2021)
5.2 Mental Disorders Drugs Market Size Forecast by Application (2022-2027)
5.2.1 Global Mental Disorders Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Mental Disorders Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Mental Disorders Drugs Price Forecast by Application (2022-2027)
6 United States by Players, Type and Application
6.1 United States Mental Disorders Drugs Market Size YoY Growth 2016-2027
6.1.1 United States Mental Disorders Drugs Sales YoY Growth 2016-2027
6.1.2 United States Mental Disorders Drugs Revenue YoY Growth 2016-2027
6.1.3 United States Mental Disorders Drugs Market Share in Global Market 2016-2027
6.2 United States Mental Disorders Drugs Market Size by Players (International and Local Players)
6.2.1 United States Top Mental Disorders Drugs Players by Sales (2016-2021)
6.2.2 United States Top Mental Disorders Drugs Players by Revenue (2016-2021)
6.3 United States Mental Disorders Drugs Historic Market Review by Type (2016-2021)
6.3.1 United States Mental Disorders Drugs Sales Market Share by Type (2016-2021)
6.3.2 United States Mental Disorders Drugs Revenue Market Share by Type (2016-2021)
6.3.3 United States Mental Disorders Drugs Price by Type (2016-2021)
6.4 United States Mental Disorders Drugs Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States Mental Disorders Drugs Sales Forecast by Type (2022-2027)
6.4.2 United States Mental Disorders Drugs Revenue Forecast by Type (2022-2027)
6.4.3 United States Mental Disorders Drugs Price Forecast by Type (2022-2027)
6.5 United States Mental Disorders Drugs Historic Market Review by Application (2016-2021)
6.5.1 United States Mental Disorders Drugs Sales Market Share by Application (2016-2021)
6.5.2 United States Mental Disorders Drugs Revenue Market Share by Application (2016-2021)
6.5.3 United States Mental Disorders Drugs Price by Application (2016-2021)
6.6 United States Mental Disorders Drugs Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States Mental Disorders Drugs Sales Forecast by Application (2022-2027)
6.6.2 United States Mental Disorders Drugs Revenue Forecast by Application (2022-2027)
6.6.3 United States Mental Disorders Drugs Price Forecast by Application (2022-2027)
7 North America
7.1 North America Mental Disorders Drugs Market Size YoY Growth 2016-2027
7.2 North America Mental Disorders Drugs Market Facts & Figures by Country
7.2.1 North America Mental Disorders Drugs Sales by Country (2016-2021)
7.2.2 North America Mental Disorders Drugs Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Mental Disorders Drugs Market Size YoY Growth 2016-2027
8.2 Asia Pacific Mental Disorders Drugs Market Facts & Figures by Region
8.2.1 Asia Pacific Mental Disorders Drugs Sales by Region (2016-2021)
8.2.2 Asia Pacific Mental Disorders Drugs Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Mental Disorders Drugs Market Size YoY Growth 2016-2027
9.2 Europe Mental Disorders Drugs Market Facts & Figures by Country
9.2.1 Europe Mental Disorders Drugs Sales by Country (2016-2021)
9.2.2 Europe Mental Disorders Drugs Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Mental Disorders Drugs Market Size YoY Growth 2016-2027
10.2 Latin America Mental Disorders Drugs Market Facts & Figures by Country
10.2.1 Latin America Mental Disorders Drugs Sales by Country (2016-2021)
10.2.2 Latin America Mental Disorders Drugs Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Mental Disorders Drugs Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Mental Disorders Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Mental Disorders Drugs Sales by Country (2016-2021)
11.2.2 Middle East and Africa Mental Disorders Drugs Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Johnson & Johnson
12.1.1 Johnson & Johnson Corporation Information
12.1.2 Johnson & Johnson Description and Business Overview
12.1.3 Johnson & Johnson Mental Disorders Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Johnson & Johnson Mental Disorders Drugs Products Offered
12.1.5 Johnson & Johnson Recent Development
12.2 Pfizer
12.2.1 Pfizer Corporation Information
12.2.2 Pfizer Description and Business Overview
12.2.3 Pfizer Mental Disorders Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Pfizer Mental Disorders Drugs Products Offered
12.2.5 Pfizer Recent Development
12.3 Eli Lilly
12.3.1 Eli Lilly Corporation Information
12.3.2 Eli Lilly Description and Business Overview
12.3.3 Eli Lilly Mental Disorders Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Eli Lilly Mental Disorders Drugs Products Offered
12.3.5 Eli Lilly Recent Development
12.4 GlaxoSmithKline
12.4.1 GlaxoSmithKline Corporation Information
12.4.2 GlaxoSmithKline Description and Business Overview
12.4.3 GlaxoSmithKline Mental Disorders Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 GlaxoSmithKline Mental Disorders Drugs Products Offered
12.4.5 GlaxoSmithKline Recent Development
12.5 AstraZeneca
12.5.1 AstraZeneca Corporation Information
12.5.2 AstraZeneca Description and Business Overview
12.5.3 AstraZeneca Mental Disorders Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 AstraZeneca Mental Disorders Drugs Products Offered
12.5.5 AstraZeneca Recent Development
12.6 Bristol-Myers Squibb
12.6.1 Bristol-Myers Squibb Corporation Information
12.6.2 Bristol-Myers Squibb Description and Business Overview
12.6.3 Bristol-Myers Squibb Mental Disorders Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Bristol-Myers Squibb Mental Disorders Drugs Products Offered
12.6.5 Bristol-Myers Squibb Recent Development
12.7 Abbott Laboratories
12.7.1 Abbott Laboratories Corporation Information
12.7.2 Abbott Laboratories Description and Business Overview
12.7.3 Abbott Laboratories Mental Disorders Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Abbott Laboratories Mental Disorders Drugs Products Offered
12.7.5 Abbott Laboratories Recent Development
12.11 Johnson & Johnson
12.11.1 Johnson & Johnson Corporation Information
12.11.2 Johnson & Johnson Description and Business Overview
12.11.3 Johnson & Johnson Mental Disorders Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Johnson & Johnson Mental Disorders Drugs Products Offered
12.11.5 Johnson & Johnson Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Mental Disorders Drugs Industry Trends
13.2 Mental Disorders Drugs Market Drivers
13.3 Mental Disorders Drugs Market Challenges
13.4 Mental Disorders Drugs Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Mental Disorders Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
    Table 1. Global Mental Disorders Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
    Table 2. Major Manufacturers of Drugs for Schizophrenia
    Table 3. Major Manufacturers of Antidepressants
    Table 4. Major Manufacturers of Antipsychotics
    Table 5. Major Manufacturers of Anxiolytics
    Table 6. Major Manufacturers of Drugs for the Treatment of Substance and Alcohol Addiction
    Table 7. Major Manufacturers of Drugs for Childhood and Adolescent Mental Illness
    Table 8. Major Manufacturers of Drugs to Treat Cognitive Disorders
    Table 9. Major Manufacturers of Sleep Disorders
    Table 10. Major Manufacturers of Others
    Table 11. Global Mental Disorders Drugs Market Size Growth Rate by Application (2021-2027) & (K Units)
    Table 12. Global Mental Disorders Drugs Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
    Table 13. Global Mental Disorders Drugs Sales by Regions (2016-2021) & (K Units)
    Table 14. Global Mental Disorders Drugs Sales Market Share by Regions (2016-2021)
    Table 15. Global Mental Disorders Drugs Revenue by Regions (2016-2021) & (US$ Million)
    Table 16. Global Mental Disorders Drugs Sales Forecast by Region (2022-2027) & (K Units)
    Table 17. Global Mental Disorders Drugs Sales Market Share Forecast by Region (2022-2027)
    Table 18. Global Mental Disorders Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 19. Global Mental Disorders Drugs Revenue Market Share Forecast by Region (2022-2027)
    Table 20. Global Mental Disorders Drugs Sales by Manufacturers (2016-2021) (K Units)
    Table 21. Global Mental Disorders Drugs Sales Share by Manufacturers (2016-2021)
    Table 22. Ranking of Global Top Mental Disorders Drugs Manufacturers by Revenue (US$ Million) in 2020
    Table 23. Mental Disorders Drugs Revenue by Manufacturers (2016-2021) (US$ Million)
    Table 24. Mental Disorders Drugs Revenue Share by Manufacturers (2016-2021)
    Table 25. Global Mental Disorders Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
    Table 26. Global Mental Disorders Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mental Disorders Drugs as of 2020)
    Table 27. Key Manufacturers Mental Disorders Drugs Price (2016-2021) (USD/Pcs)
    Table 28. Mental Disorders Drugs Manufacturers Manufacturing Base Distribution and Headquarters
    Table 29. Manufacturers Mental Disorders Drugs Product Type
    Table 30. Date of International Manufacturers Enter into Mental Disorders Drugs Market
    Table 31. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 32. Global Mental Disorders Drugs Sales by Type (2016-2021) (K Units)
    Table 33. Global Mental Disorders Drugs Sales Share by Type (2016-2021)
    Table 34. Global Mental Disorders Drugs Revenue by Type (2016-2021) (US$ Million)
    Table 35. Global Mental Disorders Drugs Revenue Share by Type (2016-2021)
    Table 36. Mental Disorders Drugs Average Selling Price (ASP) by Type (2016-2021) & (USD/Pcs)
    Table 37. Global Mental Disorders Drugs Sales Forecast by Type (2022-2027) & (K Units)
    Table 38. Global Mental Disorders Drugs Sales Market Share Forecast by Type (2022-2027)
    Table 39. Global Mental Disorders Drugs Revenue Forecast V (2022-2027) & (US$ Million)
    Table 40. Global Mental Disorders Drugs Revenue Market Share Forecast by Type (2022-2027)
    Table 41. Global Mental Disorders Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Pcs)
    Table 42. Global Mental Disorders Drugs Sales by Application (2016-2021) (K Units)
    Table 43. Global Mental Disorders Drugs Sales Share by Application (2016-2021)
    Table 44. Global Mental Disorders Drugs Revenue by Application (2016-2021) (US$ Million)
    Table 45. Global Mental Disorders Drugs Revenue Share by Application (2016-2021)
    Table 46. Mental Disorders Drugs Average Selling Price (ASP) by Application (2016-2021) & (USD/Pcs)
    Table 47. Global Mental Disorders Drugs Sales Forecast by Application (2022-2027) & (K Units)
    Table 48. Global Mental Disorders Drugs Sales Market Share Forecast by Application (2022-2027)
    Table 49. Global Mental Disorders Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 50. Global Mental Disorders Drugs Revenue Market Share Forecast by Application (2022-2027)
    Table 51. Global Mental Disorders Drugs Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Pcs)
    Table 52. United States Mental Disorders Drugs Sales (K Units) of Key Companies (2016-2021)
    Table 53. United States Mental Disorders Drugs Sales Share by Company (2016-2021)
    Table 54. United States Mental Disorders Drugs Revenue (US$ Million) by Company (2016-2021)
    Table 55. United States Mental Disorders Drugs Revenue Share by Company (2016-2021)
    Table 56. United States Mental Disorders Drugs Sales (K Units) by Type (2016-2021)
    Table 57. United States Mental Disorders Drugs Sales Share by Type (2016-2021)
    Table 58. United States Mental Disorders Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
    Table 59. United States Mental Disorders Drugs Price (USD/Pcs) by Type (2016-2021)
    Table 60. United States Mental Disorders Drugs Sales (K Units) by Type (2022-2027)
    Table 61. United States Mental Disorders Drugs Sales Share by Type (2022-2027)
    Table 62. United States Mental Disorders Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
    Table 63. United States Mental Disorders Drugs Revenue Share by Type (2022-2027)
    Table 64. United States Mental Disorders Drugs Price (USD/Pcs) by Type (2022-2027)
    Table 65. United States Mental Disorders Drugs Sales (K Units) by Application (2016-2021)
    Table 66. United States Mental Disorders Drugs Sales Share by Application (2016-2021)
    Table 67. United States Mental Disorders Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
    Table 68. United States Mental Disorders Drugs Price (USD/Pcs) by Application (2016-2021)
    Table 69. United States Mental Disorders Drugs Sales (K Units) by Application (2022-2027)
    Table 70. United States Mental Disorders Drugs Sales Share by Application (2022-2027)
    Table 71. United States Mental Disorders Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
    Table 72. United States Mental Disorders Drugs Revenue Share by Application (2022-2027)
    Table 73. United States Mental Disorders Drugs Price (USD/Pcs) by Application (2022-2027)
    Table 74. North America Mental Disorders Drugs Sales by Country (2016-2021) & (K Units)
    Table 75. North America Mental Disorders Drugs Sales Market Share by Country (2016-2021)
    Table 76. North America Mental Disorders Drugs Revenue by Country (2016-2021) & (US$ Million)
    Table 77. North America Mental Disorders Drugs Revenue Market Share by Country (2016-2021)
    Table 78. Asia Pacific Mental Disorders Drugs Sales by Region (2016-2021) & (K Units)
    Table 79. Asia Pacific Mental Disorders Drugs Sales Market Share by Region (2016-2021)
    Table 80. Asia Pacific Mental Disorders Drugs Revenue by Region (2016-2021) & (US$ Million)
    Table 81. Asia Pacific Mental Disorders Drugs Revenue Market Share by Region (2016-2021)
    Table 82. Europe Mental Disorders Drugs Sales by Country (2016-2021) & (K Units)
    Table 83. Europe Mental Disorders Drugs Sales Market Share by Country (2016-2021)
    Table 84. Europe Mental Disorders Drugs Revenue by Country (2016-2021) & (US$ Million)
    Table 85. Europe Mental Disorders Drugs Revenue Market Share by Country (2016-2021)
    Table 86. Latin America Mental Disorders Drugs Sales by Country (2016-2021) & (K Units)
    Table 87. Latin America Mental Disorders Drugs Sales Market Share by Country (2016-2021)
    Table 88. Latin Americaa Mental Disorders Drugs Revenue by Country (2016-2021) & (US$ Million)
    Table 89. Latin America Mental Disorders Drugs Revenue Market Share by Country (2016-2021)
    Table 90. Middle East and Africa Mental Disorders Drugs Sales by Country (2016-2021) & (K Units)
    Table 91. Middle East and Africa Mental Disorders Drugs Sales Market Share by Country (2016-2021)
    Table 92. Middle East and Africa Mental Disorders Drugs Revenue by Country (2016-2021) & (US$ Million)
    Table 93. Middle East and Africa Mental Disorders Drugs Revenue Market Share by Country (2016-2021)
    Table 94. Johnson & Johnson Corporation Information
    Table 95. Johnson & Johnson Description and Business Overview
    Table 96. Johnson & Johnson Mental Disorders Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 97. Johnson & Johnson Mental Disorders Drugs Product
    Table 98. Johnson & Johnson Recent Development
    Table 99. Pfizer Corporation Information
    Table 100. Pfizer Description and Business Overview
    Table 101. Pfizer Mental Disorders Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 102. Pfizer Product
    Table 103. Pfizer Recent Development
    Table 104. Eli Lilly Corporation Information
    Table 105. Eli Lilly Description and Business Overview
    Table 106. Eli Lilly Mental Disorders Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 107. Eli Lilly Product
    Table 108. Eli Lilly Recent Development
    Table 109. GlaxoSmithKline Corporation Information
    Table 110. GlaxoSmithKline Description and Business Overview
    Table 111. GlaxoSmithKline Mental Disorders Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 112. GlaxoSmithKline Product
    Table 113. GlaxoSmithKline Recent Development
    Table 114. AstraZeneca Corporation Information
    Table 115. AstraZeneca Description and Business Overview
    Table 116. AstraZeneca Mental Disorders Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 117. AstraZeneca Product
    Table 118. AstraZeneca Recent Development
    Table 119. Bristol-Myers Squibb Corporation Information
    Table 120. Bristol-Myers Squibb Description and Business Overview
    Table 121. Bristol-Myers Squibb Mental Disorders Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 122. Bristol-Myers Squibb Product
    Table 123. Bristol-Myers Squibb Recent Development
    Table 124. Abbott Laboratories Corporation Information
    Table 125. Abbott Laboratories Description and Business Overview
    Table 126. Abbott Laboratories Mental Disorders Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 127. Abbott Laboratories Product
    Table 128. Abbott Laboratories Recent Development
    Table 129. Mental Disorders Drugs Market Trends
    Table 130. Mental Disorders Drugs Market Drivers
    Table 131. Mental Disorders Drugs Market Challenges
    Table 132. Mental Disorders Drugs Market Restraints
    Table 133. Mental Disorders Drugs Customers List
    Table 134. Mental Disorders Drugs Distributors List
    Table 135. Research Programs/Design for This Report
    Table 136. Key Data Information from Secondary Sources
    Table 137. Key Data Information from Primary Sources
List of Figures
    Figure 1. Mental Disorders Drugs Product Picture
    Figure 2. Global Mental Disorders Drugs Sales Market Share by Type in 2020 & 2027
    Figure 3. Drugs for Schizophrenia Product Picture
    Figure 4. Antidepressants Product Picture
    Figure 5. Antipsychotics Product Picture
    Figure 6. Anxiolytics Product Picture
    Figure 7. Drugs for the Treatment of Substance and Alcohol Addiction Product Picture
    Figure 8. Drugs for Childhood and Adolescent Mental Illness Product Picture
    Figure 9. Drugs to Treat Cognitive Disorders Product Picture
    Figure 10. Sleep Disorders Product Picture
    Figure 11. Others Product Picture
    Figure 12. Global Mental Disorders Drugs Sales Market Share by Application in 2020 & 2027
    Figure 13. Children
    Figure 14. Adolescents
    Figure 15. Adults
    Figure 16. Mental Disorders Drugs Report Years Considered
    Figure 17. Global Mental Disorders Drugs Market Size, (US$ Million), 2016 VS 2021 VS 2027
    Figure 18. Global Mental Disorders Drugs Market Size 2016-2027 (US$ Million)
    Figure 19. Global Mental Disorders Drugs Sales 2016-2027 (K Units)
    Figure 20. Global Mental Disorders Drugs Market Size Market Share by Region: 2021 Versus 2027
    Figure 21. Global Mental Disorders Drugs Sales Market Share by Region (2016-2021)
    Figure 22. Global Mental Disorders Drugs Sales Market Share by Region in 2020
    Figure 23. Global Mental Disorders Drugs Revenue Market Share by Region (2016-2021)
    Figure 24. Global Mental Disorders Drugs Revenue Market Share by Region in 2020
    Figure 25. Global Mental Disorders Drugs Sales Share by Manufacturer in 2020
    Figure 26. The Top 10 and 5 Players Market Share by Mental Disorders Drugs Revenue in 2020
    Figure 27. Mental Disorders Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 28. Global Mental Disorders Drugs Sales Market Share by Type (2016-2021)
    Figure 29. Global Mental Disorders Drugs Sales Market Share by Type in 2020
    Figure 30. Global Mental Disorders Drugs Revenue Market Share by Type (2016-2021)
    Figure 31. Global Mental Disorders Drugs Revenue Market Share by Type in 2020
    Figure 32. Global Mental Disorders Drugs Sales Market Share by Application (2016-2021)
    Figure 33. Global Mental Disorders Drugs Sales Market Share by Application in 2020
    Figure 34. Global Mental Disorders Drugs Revenue Market Share by Application (2016-2021)
    Figure 35. Global Mental Disorders Drugs Revenue Market Share by Application in 2020
    Figure 36. United States Mental Disorders Drugs Sales Growth Rate 2016-2027 (K Units)
    Figure 37. United States Mental Disorders Drugs Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 38. United States Mental Disorders Drugs Market Share in Global Market 2016-2027
    Figure 39. United States 5 and 10 Largest Mental Disorders Drugs Players Market Share by Revenue in Mental Disorders Drugs in 2020
    Figure 40. United States Mental Disorders Drugs Revenue Share by Type (2016-2021)
    Figure 41. United States Mental Disorders Drugs Revenue Growth Rate by Type in 2016 & 2020
    Figure 42. United States Mental Disorders Drugs Revenue Share by Application (2016-2021)
    Figure 43. United States Mental Disorders Drugs Revenue Growth Rate by Application in 2016 & 2020
    Figure 44. North America Mental Disorders Drugs Sales Growth Rate 2016-2021 (K Units)
    Figure 45. North America Mental Disorders Drugs Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 46. North America Mental Disorders Drugs Sales Market Share by Country in 2020
    Figure 47. North America Mental Disorders Drugs Revenue Market Share by Country in 2020
    Figure 48. U.S. Mental Disorders Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 49. U.S. Mental Disorders Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 50. Canada Mental Disorders Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 51. Canada Mental Disorders Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 52. Europe Mental Disorders Drugs Sales Growth Rate 2016-2021 (K Units)
    Figure 53. Europe Mental Disorders Drugs Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 54. Europe Mental Disorders Drugs Sales Market Share by Country in 2020
    Figure 55. Europe Mental Disorders Drugs Revenue Market Share by Country in 2020
    Figure 56. Germany Mental Disorders Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 57. Germany Mental Disorders Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 58. France Mental Disorders Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 59. France Mental Disorders Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 60. U.K. Mental Disorders Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 61. U.K. Mental Disorders Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 62. Italy Mental Disorders Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 63. Italy Mental Disorders Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 64. Russia Mental Disorders Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 65. Russia Mental Disorders Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 66. Asia Pacific Mental Disorders Drugs Sales Growth Rate 2016-2021 (K Units)
    Figure 67. Asia Pacific Mental Disorders Drugs Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 68. Asia Pacific Mental Disorders Drugs Sales Market Share by Region in 2020
    Figure 69. Asia Pacific Mental Disorders Drugs Revenue Market Share by Region in 2020
    Figure 70. China Mental Disorders Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 71. China Mental Disorders Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 72. Japan Mental Disorders Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 73. Japan Mental Disorders Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 74. South Korea Mental Disorders Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 75. South Korea Mental Disorders Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 76. India Mental Disorders Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 77. India Mental Disorders Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 78. Australia Mental Disorders Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 79. Australia Mental Disorders Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 80. Taiwan Mental Disorders Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 81. Taiwan Mental Disorders Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 82. Indonesia Mental Disorders Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 83. Indonesia Mental Disorders Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 84. Thailand Mental Disorders Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 85. Thailand Mental Disorders Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 86. Malaysia Mental Disorders Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 87. Malaysia Mental Disorders Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 88. Philippines Mental Disorders Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 89. Philippines Mental Disorders Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 90. Vietnam Mental Disorders Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 91. Vietnam Mental Disorders Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 92. Latin America Mental Disorders Drugs Sales Growth Rate 2016-2021 (K Units)
    Figure 93. Latin America Mental Disorders Drugs Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 94. Latin America Mental Disorders Drugs Sales Market Share by Country in 2020
    Figure 95. Latin America Mental Disorders Drugs Revenue Market Share by Country in 2020
    Figure 96. Mexico Mental Disorders Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 97. Mexico Mental Disorders Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 98. Brazil Mental Disorders Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 99. Brazil Mental Disorders Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 100. Argentina Mental Disorders Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 101. Argentina Mental Disorders Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 102. Middle East and Africa Mental Disorders Drugs Sales Growth Rate 2016-2021 (K Units)
    Figure 103. Middle East and Africa Mental Disorders Drugs Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 104. Middle East and Africa Mental Disorders Drugs Sales Market Share by Country in 2020
    Figure 105. Middle East and Africa Mental Disorders Drugs Revenue Market Share by Country in 2020
    Figure 106. Turkey Mental Disorders Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 107. Turkey Mental Disorders Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 108. Saudi Arabia Mental Disorders Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 109. Saudi Arabia Mental Disorders Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 110. U.A.E Mental Disorders Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 111. U.A.E Mental Disorders Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 112. Mental Disorders Drugs Value Chain
    Figure 113. Channels of Distribution
    Figure 114. Distributors Profiles
    Figure 115. Bottom-up and Top-down Approaches for This Report
    Figure 116. Data Triangulation
    Figure 117. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3900
This license allows only one user to access the PDF.

Electronic (PDF)
$5850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$7800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
SecuX Technology Inc

RELATED REPORTS

Global and China Bipolar Disorder Market Size Status and Forecast 2021 2027
Global and China Bipolar Disorder Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-25G6547
Thu Sep 02 00:00:00 UTC 2021

Add to Cart

Global Quetiapine Fumarate Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
Global Quetiapine Fumarate Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

In 2020 the global Quetiapine Fumarate market size was US 163.3 million and it is expected to reach US 139.8 million by the end of 2027 with a CAGR of 2.2 during 20212027.Global Quetiapine Fumarate Market Size Manufacturers Supply Chain Sales Channel and Clients 20212027.

120 Pages
Type: Report
Code: QYRE-Auto-9U784
Fri Aug 13 00:00:00 UTC 2021

Add to Cart

China Affective Computing Market Report Forecast 2021 2027
China Affective Computing Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-13P2526
Fri Aug 13 00:00:00 UTC 2021

Add to Cart

Global Trazodone Hydrochloride API Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
Global Trazodone Hydrochloride (API) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-10T333
Fri Aug 13 00:00:00 UTC 2021

Add to Cart